Today's Weekly View includes ICER President and CEO Sarah Emond's perspective on the apitegromab approval (now branded Isembyld). Read here: conta.cc/4y2W6dF

#isembyld #DrugPricing #PharmaPricing #ValueBasedPricing #MarketAccess #Healthcare